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In this study, we identify a major spore surface protein, BclA, and provide evidence that this protein is glycosylated. Following
extraction of the spore surface, solubilized proteins were separated by one-dimensional PAGE and stained with glycostain to
reveal a reactive high-molecular-mass region of approximately 600 kDa. Tandemmass spectrometry analysis of in-gel digests
showed this band to contain peptides corresponding to a putative exosporangial glycoprotein (BclA3) and identified a number of
glycopeptides modified with multiple N-acetyl hexosamine moieties and, in some cases, capped with novel glycans. In addition,
we demonstrate that the glycosyltransferase gene sgtA (gene CD3350 in strain 630 and CDR3194 in strain R20291), which is lo-
cated immediately upstream of the bclA3 homolog, is involved in the glycosylation of the spore surface, and is cotranscribed with
bclA3. The presence of anti--O-GlcNAc-reactive material was demonstrated on the surface of spores by immunofluorescence
and in surface extracts byWestern blotting, although each strain produced a distinct pattern of reactivity. Reactivity of the spore
surface with the anti--O-GlcNAc antibody was abolished in the 630 and R20291 glycosyltransferase mutant strains, while com-
plementation with a wild-type copy of the gene restored the -O-GlcNAc reactivity. Phenotypic testing of R20291 glycosyltrans-
ferase mutant spores revealed no significant change in sensitivity to ethanol or lysozyme. However, a change in the resistance to
heat of R20291 glycosyltransferase mutant spores compared to R20291 spores was observed, as was the ability to adhere to and
be internalized by macrophages.
Clostridium difficile is a Gram-positive, spore-forming anaer-obe and is the major cause of antibiotic-associated diarrhea
(1). The incidence ofC. difficile infection has been rapidly increas-
ing inNorthAmerica and Europe in recent years, and this increase
in infections has been associated with higher rates of morbidity
and mortality (2). Recent estimates of the incidence of C. difficile-
associated diarrhea (CDAD) in the United States indicate asmany
as 500,000 cases per year with up to 20,000 deaths (1, 3). The
primary focus of much of the research has been on two toxins,
TcdA and TcdB, that are produced by C. difficile and cause tissue
damage and a severe inflammatory response, which can lead in the
more serious cases to potentially lethal pseudomembranous coli-
tis. While toxin activity is recognized as themajor virulence factor
associated with CDAD, other aspects of C. difficile virulence are
less well understood.
Spore production in C. difficile is an integral part of the infec-
tious process. This recalcitrant, dormant form of C. difficile can
survive indefinitely outside the host and is known to persist in the
hospital environment (4). It has been demonstrated in mice that
antibiotic treatment suppresses the diversity of the gut micro-
biome and promotes the production of these highly infectious
spores, which are then disseminated into the environment (so-
called supershedder state) (5). As such, more recently there has
been increased attention on the process of spore formation in C.
difficile as well as studies of spore structure and biochemical com-
position (6–12). To date, the major focus of the studies on spore
structure has been to identify spore coat proteins and demonstrate
enzymatic activity. Pretreatment of spores either by enzymatic
digestion or sonication was utilized in these studies to remove the
exosporangial layer prior to analysis.
In contrast to spores of C. difficile, the spores of another im-
portant toxin-producing, Gram-positive pathogen, Bacillus an-
thracis, have been extensively characterized. These spores have
been shown to be enclosed by an exosporangial layer which is
composed of a number of different proteins (13, 14) and which
includes an outermost hair-like nap layer. The filaments of the nap
layer are primarily composed of a highly immunogenic collagen-
like protein, BclA (15–17), as well as a second exosporangial pro-
tein, BclB (18). Both BclA and BclB have been well characterized
and shown to be glycosylated with an O-linked pentasaccharide
that contains the novel terminal sugar 2-O-methyl-4-(3-hydroxy-
3-methylbutamido)-4,6-dideoxy-D-glucopyranose, which is also
referred to as anthrose (16). The utility of this structure as a target
for sensitive spore detection systems (19) or as a target for thera-
peutic intervention against anthrax has been explored as well (16,
20, 21).
Although considerable progress has been made recently in the
analysis of spore coat proteins from C. difficile, the identification
and characterization of both the exosporangial and glycan-con-
taining components is less well advanced. In this study, we dem-
onstrate by mass spectrometry (MS) analysis that the BclA3 ho-
molog from C. difficile is a surface-associated glycoprotein
modified with a novel oligosaccharide. In addition, we identify a
glycosyltransferase gene which is involved in the biosynthesis of
surface-associated glycan components.
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MATERIALS AND METHODS
Bacterial strains and growth conditions. C. difficile strains used in this
study are listed in Table 1. Initial experiments were carried out using
strains 630erm and R20291. Comparisons to other C. difficile strains
from a variety of ribotypes (QCD-32g58, BI-6, CD20, CF5, and M68)
revealed R20291 to be the more representative strain. R20291 is also a
more clinically relevant strain and a better sporeformer than strain 630.
For these reasons, later experiments, particularly the biological assays,
were focused on R20291 spores. All strains were routinely grown under
anaerobic conditions on brain heart infusion agar medium (BD, Sparks,
MD) supplemented with 5 g/liter yeast extract, 1.2 g/liter NaCl, 0.5 g liter
cysteine HCl, 5 mg/liter hemin, 1 mg/liter vitamin K, and 1 mg/liter res-
azurin (BHIS). Erythromycin (2.5 g/ml) and thiamphenicol (15 g/ml)
were added as required for the growth of mutant and complemented
mutant strains.
MS analysis of spores. Spores were harvested from BHIS agar plates
into phosphate-buffered saline (PBS) following 7 days of incubation un-
der anaerobic conditions, heat treated at 56°C for 15 min, collected by
centrifugation (500  g for 30 min), and washed once in PBS. Spore
numbers (CFU/ml) were determined by serial dilution and plating on
BHI containing 0.1% sodium taurocholate (BHI-ST; Sigma-Aldrich,
Oakville, Canada). Approximately 5  109 spores were resuspended in
200 l of extraction buffer (2.4 ml 1 M Tris, pH 6.8, 0.8 g ASB-14, 4 ml
100% glycerol, 1% dithiothreitol [DTT], 3.8 ml double-distilled H2O)
and were left for 30 min at room temperature. Spores were removed by
centrifugation, and soluble material was collected for analysis.
Protein-containing endospore surface extractions were separated us-
ing 3 to 8% NuPAGE Novex Tris-acetate minigels by following the man-
ufacturer’s instructions (Invitrogen, Life Technologies). High-molecular-
mass HiMark protein standards (31 to 500 kDa) were used as markers.
The gel was stained using Emerald-Q glycostain per the manufacturer’s
instructions (Invitrogen, Life Technologies) and subsequently with non-
fixing silver stain (22). Protein bands were excised, reduced for 1 hwith 10
mMDTT at 56°C, and alkylated for 1 h with 55mM iodoacetamide in the
dark (23) prior to digestion with trypsin as described previously (24) or
with proteinase K. Proteinase K digests were carried out using 100 g/ml
of enzyme in 50mMammonium bicarbonate for 15 to 40 h. The resulting
peptides were analyzed by nanoliquid chromatography coupled to tan-
dem MS (nLC-MS/MS) using electrospray ionization (ESI) as the ion
source, as recently described (24). Briefly, peptides were analyzed by
nanoflow reversed-phase liquid chromatography (RPLC) coupled to MS
using ESI (nanoRPLC-ESI-MS) using a nanoAcquity UltraPerformance
LC (UPLC) system coupled to a quadrupole-time-of-flight (Q-TOF) Ul-
tima hybridmass spectrometer (Waters,Milford,MA). The peptides were
first loaded onto a 180-m-inner-diameter (ID), 20-mm by 5-m sym-
metry C18 trap column (Waters, Milford, MA) and then eluted into a
100-m-ID, 10-cm by 1.7-m BEH130 C18 column (Waters, Milford,
MA) using a linear gradient from 1% to 45% solvent B (acetonitrile plus
0.1% formic acid) for 18min, 45% to 85% solvent B for 3min, and 85% to
1% solvent B for 1 min. Solvent A was 0.1% formic acid in high-perfor-
mance liquid chromatography (HPLC)-grade water. The peak list files of
MS/MS spectra from tryptic digests were searched against the NCBI da-
tabase using the MASCOT search engine (version 2.3.0; Matrix Science,
London, United Kingdom). Amass tolerance for precursor ions of 0.8 Da
was used for precursor and fragment ions. Ion scores of 30 and above
indicated identity. In addition, all spectral matches were verified manu-
ally.UnmatchedMS/MS spectra and allMS/MS spectra fromproteinaseK
digests were examinedmanually to determine the sequences of peptide y-
and b-type ions.
Construction of CD3350 and CDR3194 insertional mutants and
complemented mutants. The target site was identified for the CD3350
gene from C. difficile 630 using the TargeTron gene knockout system
(Sigma-Aldrich), and it was used to design a 45-bp retargeting sequence
for the gene. A derivative of plasmid pMTL007C-E2 carrying the retarget-
ing sequence was obtained from DNA2.0 (Menlo Park, CA) and used to
generate mutants in strains 630erm and R20291 according to Heap et al.
(25, 26). Aminimumof two Erm-resistant transconjugants for each strain
were checked by PCR using the ErmRAM primers to verify splicing of the
group I intron following integration and also using flanking primers for
the CD3350 gene to verify the disruption of CD3350 and CDR3194 genes
by the erm cassette.
Each of the CD3350 and CDR3194 glycosyltransferase mutant strains
were complemented with a wild-type copy of the C. difficile CD3350 gene
using plasmid pRPF185 (27). The entire coding sequence of the gene,
including the Shine-Dalgarno sequence, was cloned under the control of
the inducible Ptet promoter. Plasmids were transferred to CD3350 and
CDR3194 mutant strains via conjugation, and gene expression was in-
duced by plating onto BHIS agar containing anhydrous tetracycline at 500
ng/ml after growth to mid- to late-log phase in BHIS broth.
Western blotting. Spore samples were harvested at 72 h, resuspended
to 1  107 spores/100 l in 1 Laemmli loading buffer, and heated to
95°C for 5min. Spore extracts were separated on 3 to 8%NuPAGENovex
Tris-acetate minigels and blotted onto polyvinylidene difluoride (PVDF).
The membrane was probed with a 1:5,000 dilution of anti--O-GlcNAc
(Covance,Montreal, Canada) in PBS–0.1%Tween 20 (PBS-T). Reactivity
was detected with anti-mouse IgM horseradish peroxidase (HRP) conju-
gate (Sigma-Aldrich, Oakville, Canada) secondary antibody at a 1:10,000
dilution in PBS-T. Blots were imagedwith an ECLPrimeWestern blotting
detection kit (GE Healthcare, Baie D’Urfe, QC, Canada) according to the
manufacturer’s instructions, followed by exposure to X-ray film.
TranscriptionofCD3350andBclA3genesbyRT-PCR.Todetermine
if the CD3350 and bclA3 genes are cotranscribed, reverse transcriptase
PCR (RT-PCR) was performed using primers designed to amplify across
the intergenic region between the two genes from C. difficile 630. RNA
template was extracted from broth-grown cells (4 h) using a TRIzol ex-
traction procedure (28). All RNA samples were treated with RNase-free
DNase (Thermo Scientific) to remove contaminating DNA. RNA was
quantified and 30 ng was used for each RT-PCR using a Sensi-Script RT
kit (Qiagen) and PCR amplification using TopTaq Master. In addition,
PCR amplificationswere performedwith the same primers using genomic
DNA to verify amplicon size and specificity of primer pairs. Control PCRs
of RNA without reverse transcriptase confirmed the absence of contami-
nating DNA in samples.
Spore production for biological testing. For production of mature
spores, plates were incubated for 7 days in an anaerobic incubator (Don
Whitely Scientific, United Kingdom) on BHI at 37°C. Spores were har-
vested from agar and heat treated at 60°C for 20 min. To purify spores,
samples were washed 10 in H2O and the number of spores (CFU/ml)
determined by serial dilution and plating on BHI-ST.
TABLE 1 C. difficile strains used in this study
Strain Characteristic(s) Reference and/or source
630erm Ribotype O12 N. Minton, University of
Nottingham (44)
R20291 Ribotype O27 B. Wren, LSHTM (45)
630CD3350 630erm CD3350::erm This study
R20291CDR3194 R20291 CDR3194::erm This study
630CD3350p3350 630erm CD3350
pRPF185-CD3350
This study
R20291CDR3194p3350 R20291 CDR3194
pRPF185-CD3350
This study
QCD-32g58 Ribotype 027 A. Dascal, Jewish
General Hospital,
Montreal (46)
BI-6 Ribotype 0176 B. Wren, LSHTM
CD20 Ribotype 023 B. Wren, LSHTM
CF5 Ribotype 017 B. Wren, LSHTM (47)
M68 Ribotype 017 B. Wren, LSHTM (47)
Strong et al.
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Immunofluorescence. Spores at 1  108/ml were air dried and heat
fixed onto glass coverslips (VWR). The spores were blocked with 5%
milk-PBS for 30 min at room temperature and then incubated with a
1:100 dilution in PBS of -O-GlcNAc monoclonal antibody (Covance)
for 45 min at room temperature. Coverslips were washed with PBS-T and
then incubated with a 1:100 dilution in PBS of anti-mouse IgG plus IgM
fluorescein isothiocyanate (FITC) conjugate (Caltag, Burlingame,CA) for
45 min at room temperature in the dark. Coverslips were washed with
PBS-T and then mounted onto slides with Vectashield plus 4=,6-di-
amidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA).
Slides were examined with an Axioplan 200M (Zeiss) with multiple fields
of view observed. The experiment was performed in duplicate on at least
three independent occasions. For quantification of GlcNAc reactivity to
spores, slides were prepared as stated above using spores that had been
grown for 7 days and washed with H2O, and then they were examined by
microscopy. Using an Axioplan 200Mmicroscope (Zeiss), at least 8 fields
of view were examined per slide, with three replicate slides per sample. At
least 100 spores per slide were counted for anti--O-GlcNAc binding to
phase-bright spores. This was performed on at least three occasions to
enumerate the percentage of fullymature spores that could be boundwith
anti--O-GlcNAc.
Spore heat resistance assay. Heat resistance of C. difficile spores was
determined as previously described (7). Briefly, spores of R20291 and
CDR3194 mutant strains were resuspended in 5 ml of PBS at 1 106/ml,
with starting inoculum numbers confirmed by serial dilution and plating
on BHI-ST, and then incubated anaerobically for 24 h at 37°C. One-ml
aliquots of sporeswere heated to 80°C for 20min in awater bath, plated on
BHI-ST, and incubated anaerobically for 24 h at 37°C to determine the
number of CFU/ml. Percent survival was determined by comparing pre-
and postheat treatment CFU/ml. The experiment was performed in trip-
licate on at least three independent occasions.
Spore lysozyme resistance assay. Spores of R20291 and CDR3194
mutant strains were diluted to 1  106/ml in 5 ml PBS with starting
inoculum numbers confirmed by serial dilution as described above. Ly-
sozyme was added to a final concentration of 250 g/ml, and 1-ml sam-
ples were incubated for 1 h at 37°C. The number of CFU/ml was deter-
mined by serial dilution and plating on BHI-ST. Percent survival was
determined by comparing pre- and postlysozyme treatment CFU/ml. The
experiment was performed in triplicate on three independent occasions.
Spore ethanol resistance assay. Spores of R20291 and CDR3194 mu-
tant strains were diluted to 1  106/ml in 5 ml 70% ethanol. The time
point at which the spore count was 0 CFU/ml was confirmed by serial
dilution and plating on BHI-ST as described above. One-ml aliquots were
incubated at room temperature for 20 min, plated on BHI-ST, and incu-
bated anaerobically for 24 h at 37°C to determine the number of CFU/ml.
Percent survival was determined by comparing pre- and postethanol
treatment CFU/ml. Experiments were performed in triplicate on three
independent occasions.
Macrophage assay. J774A.1 macrophages were cultured at 5  105
cells/well on coverslips in a 24-well plate in 1 ml RPMI media supple-
mented with 10% fetal bovine serum (FBS) (R10) under 5% CO2 at 37°C
for 24 h. Spores were diluted to 5  106/ml (multiplicity of infection
[MOI], 10:1) in R10, and CFU/ml was calculated by dilution series and
plating on BHI-ST. J774A.1 cells were washed with PBS, and then 1-ml
spores were added to four replicate wells. The plate was incubated for 30
min at 37°C and 5% CO2, and then wells were washed with PBS before
cells were fixed with 250l 4% formaldehyde for 15min at room temper-
ature. Cells were washed with PBS and then incubated with a rabbit an-
ti-C. difficile polyclonal antisera (CD3) at a 1:100 dilution in PBS for 45
min at room temperature. Coverslips were washed with PBS and then
incubated with anti-rabbit Alexa fluor 488 (Invitrogen) at a 1:1,000 dilu-
tion in PBS for 45min at room temperature. Coverslips were washed with
PBS, and then cells were permeabilized with 0.1% Triton-PBS for 15 min
at room temperature. Coverslips were washed with PBS and then incu-
bated for 45 min at room temperature in a 1:100 dilution of CD3 antisera
in PBS. Coverslips were washed in PBS and then incubated in a 1:1,000
dilution of anti-rabbit Alexa Fluor 594 (Invitrogen) for 45 min at room
temperature. Coverslips were washed with PBS and then mounted onto
slides with Vectashield plus DAPI (Vector Laboratories) and sealed with
nail polish. Slides were examined with an Axioplan 200M microscope
(Zeiss). Three coverslips per strain, with 50 J774A.1 cells per coverslip,
were counted utilizing z stack images to gain a three-dimensional (3D)
representation of the cell. Adhesion and internalization were quantified
by counting adhered (red/green) and internalized (red) spores and calcu-
lating percent adhered or internalized per J774A.1 cell based on known
MOIs. The assay was performed in triplicate on three independent occa-
sions.
Statistical analysis. Student’s t test with Welch’s correction was used
for pairwise comparisons.
RESULTS
Bioinformatic identification of BclA and BclB homologs in
strains of Clostridium difficile. The Gram-positive spore-form-
ing bacterium Bacillus anthracis elaborates two glycosylated spore
surface proteins, denoted BclA (BAS1130; GenBank accession
number YP_027402 in strain Sterne) and BclB (BAS2281;
YP_028542 in strain Sterne), for Bacillus collagen-like protein
(Fig. 1a). Homologs of BclA have also been found within the ge-
nome sequences of Bacillus cereus and Bacillus thuringiensis (29).
BLAST searches of the BclA and BclB sequences against genome
sequences of three C. difficile strains revealed Bcl protein ho-
mologs.C. difficile 630, the first strain to have a completed genome
sequence, had three ORFs with homology to BclA and BclB. These
were found in different regions of the C. difficile 630 genome, as
shown in Fig. 1b. Percent homology and expect (E) values of sig-
nificance are shown in Table 2. The open reading frame (ORF)
CD3349 was annotated BclA3 (YP_001089866) despite showing
greater homology to BclB; therefore, we refer to this protein as
BclA3 to remain consistent with the genome annotation. Figure
1b also shows C. difficile 630 CD3349 (BclA3; YP_001089866) to
be located 66 bp downstream of a putative glycosyltransferase
(CD3350; YP_001089867). The glycosyltransferase gene has high
homology to a B. anthracis glycosyltransferase (BAS 1131;
YP_027403) that is likely responsible for the transfer of carbohy-
drate components to exosporangial proteins in this species. The
proximity of the genes and high homology with genes of known
function within B. anthracis provided early suggestions that C.
difficile exosporangial proteins are glycosylated.
We next searched the genomes of C. difficile strains QCD-
32g58 and R20291. Within the strain QCD-32g58 genome, only a
single ORF had significant homology to the Bcl proteins;
CdifQ_040500019311 (WP_009891815) showed 62% homology
to BclA and 50% homology to BclB of B. anthracis. A BLAST
search of the glycosyltransferase gene BAS 1131 against the QCD-
32g58 genome sequence showed a homolog, a putative glycosyl-
transferase (CdifQ_040500019316; WP_009891817), 78 bp up-
stream of the putative exosporium glycoprotein gene (CdifQ_
040500019311). The genome of strain R20291 contained two bcl
gene homologs, with the translated product of CDR20291_3090
(BclA2; YP_003219565) showing 64% homology to B. anthracis
BclB and that of CDR20291_3193 (BclA3; YP_003219669) show-
ing 56% homology to B. anthracis BclA. In addition, CDR20291_
3194 (YP_003219670), which lies 78 bp downstream of BclA3,
showed 46% identity to the B. anthracis glycosyltransferase (Ta-
ble 2).
In all three strains, the Bcl protein homologs have only short,
C. difficile Spore Glycosylation Patterns
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trypsin-susceptible regions (as predicted by amino acid sequence)
at the N and C termini. The central region of the Bcl protein
homologs is comprised of approximately 40 kDa of collagen-like
repeats with no predicted trypsin cleavage site. The three C. diffi-
cile glycosyltransferase homologs have identical sequences apart
from a single conserved amino acid substitution at the third
amino acid in the sequence.
Characterization ofC. difficile exosporangial surface extrac-
tion. Previous studies have demonstrated that C. difficile spores
possess an exosporangial layer which surrounds the spore coat,
and this layer has been shown to be structurally variable among
isolates (6, 30, 31). Various treatments of spores have been utilized
to remove this layer, which allowed the characterization of the
underlying spore coat (7, 8, 30, 32). The structural components of
FIG 1 Schematic diagram showing the genetic organization of the putative C. difficile exosporium glycoprotein genes and related glycosyltransferase gene. (a)
Bacillus anthracis Sterne strain has been shown to possess two exosporium glycoprotein genes, BAS 1130 and 2281 (colored black in the figure) denoted bclA and
bclB. A glycosyltransferase has also been identified lying adjacent to bclA (BAS 1131, denotedwhite). Genetic organization of the bcl homologs (black arrows) and
putative glycosyl transferase sgtA (white arrows) in C. difficile 630 (b), R20291 (c), and QCD-32g58 (d).
TABLE 2 BLAST search of Bacillus anthracis exosporangial glycoprotein (BclA and BclB) translated gene sequences against selected Clostridium
difficile translated genomes
B. anthracis strain
Sterne protein
% Sequence identity toa:
C. difficile strain 630 C. difficile strain R20291
C. difficile strain
QCD-32g58
Exosporium
glycoprotein
BclA1
Exosporium
glycoprotein
BclA2
Exosporium
glycoprotein
BclA3
Glycosyl
transferase
Exosporium
glycoprotein
BclA2
Exosporium
glycoprotein
BclA3
Glycosyl
transferase
Putative
exosporium
glycoprotein
BclA3
Glycosyl
transferase
BclA 60 (2e68) 57 (4e49) 49 (1e41) 56 (1e52) 56 (7e32) 62 (7e41)
BclB 69 (1e38) 62 (2e34) 50 (1e35) 64 (8e37) 50 (1e35) 50 (3e35)
Glycosyl transferase 47 (7e114) 46 (4e113) 46 (4e113)
a Shown are the percent sequence identities and E values (in parentheses).
Strong et al.
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the exosporangial layer have yet to be characterized; thus, in this
study we focused on identifying and characterizing spore surface-
associated protein components. Using a detergent-based extrac-
tion, we removed surface-associated components from spore
preparations which had not been extensively water washed or
treated with enzymes/sonication to facilitate retention of surface
structures. Endospores of strains 630, QCD-32g58, and R20291
were incubated in detergent solutions to extract the spore surface
proteins, and then intact spores were removed by centrifugation.
The protein-containing supernatants were resolved by a 3 to 8%
NuPAGE gradient gel. The high-molecular-mass region of the gel
shows diffuse banding patterns reactive with both silver stain
(Fig. 2a) and glycostain (Fig. 2b), suggesting high-molecular-mass
complexes containing glycoproteins. Proteinase K digestion of
spores had only amarginal effect on themigration of thismaterial,
suggesting a more complex composition. A pattern of staining in
this region distinct from that of strain 630 was obtained for
R20291 and QCD32g58 spore extracts. Glycostaining revealed a
reactive high-molecular-mass band in R20291 andQCD32g58 ex-
tracts only.
Initially, extraction of all gel bands of molecular masses of
160 kDa was performed, and each band was digested with either
trypsin or proteinase K and analyzed by nLC-MS/MS. No BclA
protein identification was made from these analyses. Subse-
quently, the high-molecular-mass region (160 kDa) of each lane
was excised in bands and digested with trypsin or proteinase K.
The trypsin digests for all three strains did not result in any protein
identifications by nLC-MS/MS. Analysis of the MS/MS spectra
from proteinase K digests, however, yielded several spore surface
protein identifications, as indicated by the numbered annotations
in Fig. 2a, lane 3, and summarized in Table 3 for R20291 and Fig.
S1 in the supplemental material for QCD-32g58.
De novo sequencing of the peptide MS/MS spectra from the
proteinase K digests of gel bands 1 to 3 from surface extract of
R20291 spores revealed a number of peptides that corresponded
to the putative exosporium glycoprotein BclA3 (CDR20291_
3193). Further inspection of the MS/MS spectra showed peptides
FIG 2 NuPAGE gel analysis of C. difficile endospore surface protein extracts.
(a) Silver-stained 3 to 8% NuPAGE; (b) Pro-Emerald Q glycostain 3 to 8%
NuPAGE. Lane 1, HiMark-prestained molecular mass marker; lane 2,
630erm spore surface extract; lane 3, R20291 spore surface extract; lane 4,
QCD-32g58 spore surface extract. Arrows indicate regions of the gel that were
excised, enzymatically digested, and analyzed by nLC-MS/MS.
TABLE 3 nLC-MS/MS analysis of glycoreactive peptidesa
Gel band Accession no. (designation)
Protein (molecular mass,
kDa) Peptide sequence
Glycan mass, Da (monosaccharide
neutral losses, Da)
1 YP_003219669 (CDR20291_3193) Exosporium glycoprotein
BclA3 (59.5)
308AGLIGPTGATGV319 609 (203-203-203)
145TGPTGATGADGITGP159 983 (203-203-203-374)
344VGPTGATGA352b 406 (203-203)
189GLIGPTGATGTPGA202 406 (203-203)
278TGATGLIGPTGATGA292 1,186 (203-203-203-203-374)
278TGATGLIGPTGATGA292 1,241 (203-203-203-203-429)
212TGIGITGPTGATGA225c 1,184 (203-203-203-203-372)
212TGIGITGPTGA222d 1,095 (203-203-203-486)
309GLIGPTGATGVTGA322 1,071 (203-203-203-462)
299TGVTGATGAAGLIGP313 609 (203-203-203)
2 YP_003219669 (CDR20291_3193) Exosporium glycoprotein
BclA3 (59.5)
278TGATGLIGPTGATGA202 1,187 (203-203-203-203-375)
191IGPTGATGTPGATGPTGA208 1,661 (203-203-203-222-203-203-424)
424TGPTGATGPTGADGL438 609 (203-203-203)
3 YP_003219669 (CDR20291_3193) Exosporium glycoprotein
BclA3 (59.5)
119GVTGPTGPTGPTGATGA135 609 (203-203-203)
169GVTGPTGPTGATGV182 609 (203-203-203)
344VGPTGATGATGADGL358 609 (203-203-203)
359VGPTGPTGATGV370 609 (203-203-203)
191IGPTGATGTPGATGPTGA208 609 (203-203-203)
311IGPTGATGVTGADGA325 609 (203-203-203)
439VGPTGATGATGL450 609 (203-203-203)
391VGPTGATGATGADGV405 609 (203-203-203)
359VGPTGPTGATGV370 203
656ATASGLSLVNTVA668
a High-molecular-mass gel bands of R20291 spore surface extracts were digested with proteinase K, and the numbering of gel bands refers to that of Fig. 2. MS/MS spectra were de
novo sequenced, and the identified peptides and observed glycan moieties are indicated.
b This sequence was also found at amino acids 391 to 399, 439 to 447, and 487 to 495.
c This sequence was also found at amino acids 259 to 272.
d This sequence was also found at amino acids 259 to 269.
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with ions that did not correspond to peptide y- or b-type ions but
were characteristic of carbohydrate-associated fragment ions. For
example, from tandemmass spectrometry analyses of band 1 (Fig.
2a), which migrated to a molecular mass of greater than 600 kDa,
the MS/MS spectrum of the putative glycoprotein peptide
AGLIGPTGATGV modified with three N-acetyl hexosamine
(HexNAc) moieties is shown in Fig. 3A. The glycan modification
was observed as sequential neutral losses of 203 Da from the gly-
FIG 3 Mass spectrometry analysis of peptides from proteinase K digestion of C. difficile R20291 endospore surface extracts. (a) nLC-MS/MS spectrum of the
doubly protonated glycopeptide ion at m/z 811.8. Peptide type y and b ions were visible and gave the peptide sequence AGLIGPTGATGV, a peptide from the
BclA3 protein. The spectrum was dominated in the high-m/z region by sequential neutral losses of 203 Da, with the unmodified peptide ion observed at m/z
1,013.5. Combined with the observed intense glycan oxonium ion at m/z 204 and neutral losses of water to give glycan-related ions at m/z 186 and 168, this
spectrum suggested the peptide was modified with a chain of 3 HexNAc moieties. (b) nLC-MS/MS spectrum of a doubly protonated glycopeptides ion at m/z
1,129. Peptide type y and b ions corresponded to a sequence of TGPTGATGADGITGP, corresponding to the BclA3 protein. The high-m/z region of the spectrum
was dominated by sequential neutral losses of 374 Da, 203 Da, 203 Da, and 203 Da. An intense oxonium ion was observed atm/z 375, and a very weak oxonium
ionwas observed atm/z 204 (not indicated). Glycan-related fragment ionswere observed atm/z 300 and 272. (c) Peptide sequence coveragemap of BclA3 protein
homolog from spore surface protein extraction (band 1). Boldface and underlining indicate peptides modified with glycan moieties. Two of the peptides shown
to be modified with glycan are shown in boldface gray text to indicate that the amino acid sequence appears in the BclA3 protein more than once. Dotted
underlining indicates a glycopeptide sequence that is common to both BclA3 and BclA2 proteins.
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copeptide precursor ion in the high-m/z region of the MS/MS
spectrum. In addition, an intense glycan oxonium ion was ob-
served at m/z 204 which was common to all of the identified gly-
copeptides. In addition, more complex glycosylation patterns
were observed in some cases, with intense ions observed in glyco-
peptide spectra that did not correspond to HexNAc residues or
peptide type y or b fragment ions (for example, oxonium ions
corresponding to masses of 486 Da, 372 Da, and 374 Da). Figure
3b shows an MS/MS spectrum of the BclA peptide TGPTGAT
GADGITGP modified with three HexNAc moieties and an addi-
tional mass of 374 Da. The sequential neutral losses suggest that
HexNAc is the linking sugar. This glycan neutral mass was also
linked to a putative glycan oxonium ion atm/z 375. Other intense
ions were also observed in the low-m/z region of thisMS/MS spec-
trum, including putative glycan fragment ions atm/z 300 and 272.
The absence of potential N-linked glycosylation sites suggested
the glycans are O-linked through threonine residues within each
peptide. Observed sequential neutral losses of 203 Da in the high-
m/z region of the spectrum and the presence of an intense ion
corresponding to the unmodified form of the peptide suggest the
glycan is composed of oligosaccharide chains attached to a single-
amino-acid residue in each identified glycopeptide.
Table 3 shows the complete list of surface protein peptides and
glycopeptides identified from each of the annotated bands indi-
cated in Fig. 2a. The unknown glycans varied in observed mass
from 281 to 486 Da, and it is possible that these are modified
HexNAc moieties. Tandemmass spectrometry analysis of protei-
nase K digests of bands 2 and 3 showed BclA3 glycopeptides mod-
ified with chains of HexNAc moieties, predominantly in trimers.
In these cases, only peptidesmodifiedwithHexNAcmoieties were
observed at detectable levels.
All of the identified glycopeptides reside within the central col-
lagen-like repeating domain of the BclA3 protein; however, sam-
ple limitations prohibited the identification of the precise sites of
modification within the respective peptides or further character-
ization of the glycan moieties. The central collagen-like repeat
domains of the putative exosporial proteins contained some
nonunique regions, which resulted in the identification of multi-
ple glycopeptides with amino acid sequences that repeat within
the protein sequence (for example, TGIGITGPTGA occurs in
BclA3 at residues 212 to 222 and 259 to 269). One of the identified
peptides, which also happens to be repeated in BclA3 four times, is
also common to both BclA3 and BclA2 (VGPTGATGA). The
nonspecific cleavage by proteinase K produced a number of gly-
copeptides with overlapping sequences. Furthermore, multiple
glycopeptides were identified that possessed identical peptide se-
quences but different glycans.
As indicated above, strains R20291 and QCD-32g58 showed
similar protein staining patterns for both silver stain and glyco-
stains, and nLC-MS/MS analysis also showed that the Bcl protein
of QCD-32g58 is similarly glycosylated predominantly with Hex-
NAc moieties (see Fig. S1 in the supplemental material). nLC-
MS/MS analysis of the gel digests from strain 630, which showed
significantly different staining patterns in the high-molecular-
mass region of the gel compared to the other two strains, did not
yield any protein or glycoprotein identifications.
Anti--O-GlcNAc reactivity ofC. difficile spores.As themost
abundant glycan modification observed in the MS analysis of
spore surface-extracted material was shown to have a mass corre-
sponding to an N acetyl-hexosamine moiety, we next examined
the ability of spores to bind to an O-linked N-acetylglucosamine
(-O-GlcNAc) antibody. A monoclonal antibody (MAb) which
recognizes O-GlcNAc in a -O-glycosidic linkage to both threo-
nine and serine was utilized in immunofluorescence experiments
with intact spores from a number of C. difficile clinical isolates
(Fig. 4a). This antibody had been used previously to demonstrate
the presence of -O-GlcNAc attached to serine and threonine
residues of Listeria monocytogenes flagellin (33).
When the -O GlcNAc antibody was used in immunofluores-
cence reactions with spores of R20291 and 630erm, both spore
preparations reacted strongly with the antibody. Interestingly,
distinct patterns of reactivity with the spore surface were observed
by this immunofluorescence method for each strain (Fig. 4a).
With R20291 spores, anti--O-GlcNAc was uniformly reactive
over the entire spore surface, while with strain 630erm, anti--
O-GlcNAc reactivity was restricted to the poles of the spores with
only limited labeling of the central surface (Fig. 4a, arrows). Veg-
etative cells of both strains showed no reactivity with anti--O-
GlcNAc (see Fig. S2 in the supplementalmaterial). To confirm the
conservation of-O-GlcNAc on the surface of multipleC. difficile
strains, a range of spores from different ribotypes and geographic
locations were also tested for anti--O-GlcNAc binding. The re-
activity pattern observed for R20291 spores was found to be con-
served in all strains examined, with the only exception being
spores of 630erm (Fig. 4a). Any unstained cells in the images
were either immature spores or cell debris from the washing pro-
cess. DAPI binding was observed only with vegetative cells and
immature phase-dark spores; phase-bright spores were consid-
ered mature.
RT-PCR of CD3350-bclA3 gene locus. As indicated in Fig. 1,
CD3350 (B. anthracis exosporangial glycosyltransferase gene ho-
molog) and bclA3 lie immediately adjacent to each other and are
orientated in the same direction on the chromosome in both 630
and R20291 strains. The two genes are separated by only a short
intergenic region, suggesting they form a single transcriptional
unit. Primers which amplified across this intergenic region were
used to determine if the genes were cotranscribed. RNA samples
extracted from C. difficile 630 cells were subjected to reverse tran-
scription, and an amplification product of 257 bp linking CD3350
and bclA3 was obtained, confirming cotranscription of these two
genes (see Fig. S3 in the supplemental material). PCRs using the
same primers and total RNA that had not undergone a reverse
transcriptase reaction did not yield any amplification product,
demonstrating that the RNA was free of contaminating DNA.
Mutagenesis of CD3350 and CDR3194 and spore character-
ization. We next generated insertionally inactivated glycosyl-
transferase mutants in strains 630erm and R20291 (CD3350
and CDR3194) by using ClosTron technology as previously de-
scribed (26). Insertion of the TargeTron Erm resistance marker
was confirmed by PCR using primers flanking the gene of interest
andwith primers specific to the TargeTron Erm resistancemarker
(data not shown). Vegetative cell growth of both CD3350 and
CDR3194 was unchanged compared to that of their respective
parent strains, and motility was unaffected (data not shown). Im-
munofluorescence of spores with anti--O-GlcNAc antibody re-
vealed a complete loss of reactivity for both CD3350 and
CDR3194 compared to the respective parent strains (Fig. 4b).
The percentage of wild-type spores compared to mutant phase-
bright spores reacting with anti--O-GlcNAc antibody was quan-
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tifiedmicroscopically and shown to be 80 to 95% compared to less
than 1% for the respective mutants (Fig. 4c).
Both CDR3194 and CD3350 strains were complemented
with wild-type copies of CD3350 using pRPF185 (27), as evi-
denced by both Western blotting and immunofluorescence stud-
ies (Fig. 5; also see Fig. S4 in the supplemental material). As can be
seen in Fig. 5, lanes 2 and 5, a positive reaction was observed in
Western blotting with spore surface extracts from both R20291
and 630erm spores, respectively. Spore extracts of R20291 dis-
played reactivity with the region of gel corresponding to band 4
(approximately 400 kDa) fromMS analysis. In addition, a second
strongly reactive band migrating at a molecular mass of approxi-
mately 170 kDa on 3 to 8% NuPAGE gel was observed, although
we were unable to identify peptides from a proteinase K digestion
of this region of the gel by MS analysis. For strain 630erm, no
reactivity was observed in the corresponding higher-molecular-
mass region of the gel, and a series of three distinct reactive bands
was observed at approximately 170 kDa. All reactivity was lost in
CD3350 and CDR3194 mutant strains, while the strain-specific
pattern of reactivity was restored upon complementation (Fig. 5;
also see Fig. S4). On the basis of these results, we now propose that
this gene be renamed sgtA (spore glycosyl transferase).
Characterization of sgtA spore surface extract. In parallel
with the spore surface protein extracts of the wild-type strain,
spore surface extracts of the R20291sgtAmutant strain were also
prepared and analyzed by 3 to 8% NuPAGE Tris-acetate gels to
resolve high-molecular-mass material. The protein-stained gel
shows a diffuse area of staining at 460 kDa and greater; however,
the distinct 	600-kDa band was not observed. Similarly, glyco-
staining of the same gel showed no detectable reactivity at 	600
FIG 4 Immunofluorescence of anti--O-GlcNAc binding to spores. (a) Wild-type spores of C. difficile strains from a range of ribotypes and geographical
locations. For 630erm, GlcNAc binding at poles is marked with arrows. (b) sgtA mutant spores of strains R20291 and 630erm. First row, merged image of
phase contrast, DAPI, and FITC; 2nd row, DAPI channel only; 3rd row, FITC channel only; 4th row, phase-contrast image only. GlcNAc was visualized with
mouse anti--O-GlcNAc and anti-mouse IgM-FITC conjugate. (c) Percentage of spores reacting with anti--O-GlcNAc after 7 days of growth. At least 100
spores were counted in triplicate on three independent occasions for anti--O-GlcNAc binding to the surface, as analyzed by immunofluorescence microscopy.
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kDa (see Fig. S5 in the supplemental material). In contrast to MS
studies of gel bands of R20291 spore surface extracts, which iden-
tified peptides/glycopeptides in proteinase K digests, the equiva-
lent region of the NuPAGE gel of the spore surface protein extrac-
tion of sgtA did not yield any peptide or glycopeptide
identifications. In addition, to date, our analyses of lower-molec-
ular-mass protein bands from spore surface extracts have shown
no evidence of unglycosylated BclA3.
Resistance of R20291sgtA spores. As the more clinically rel-
evant strain and as shown by immunofluorescence to be a more
representative strain of C. difficile spore morphology, phenotypic
assays were undertaken on R20291 wild-type spores and sgtA
spores. The heat resistance of spores was examined as previously
described (7). When incubated at 80°C for 20 min, sgtA spores
showed significantly lower survival rates than the parent R20291
spores (Fig. 6). The susceptibility of spores to 70%ethanol and 250
g/ml lysozyme was also examined, but no significant difference
was observed between wild-type and sgtA spores (see Fig. S6 in
the supplemental material).
Role of sgtA in adherence and internalization ofmacrophage
cells. To gain insight into a possible biological role for the SgtA
glycosyltransferase, we next investigated the ability of spores to
adhere to and be internalized by the J774A.1 macrophage cell line
(ATCC TIB-106). Spores were counted based on association with
J774A.1 cells and counted as adhered if green/red and internalized
if red. Spores not associated with cells were ignored, as were any
remaining vegetative cells based on rod shape. As can be seen in
Fig. 7, it is clear that adherence and internalization of J774A.1
macrophage cells byC. difficileR20291 spores was affected follow-
ing inactivation of the sgtA gene, with significantly greater num-
bers ofsgtA spores being internalized compared to the wild type.
DISCUSSION
This study presents, to our knowledge, the first characterization of
glycoproteins fromC. difficile spores and provides direct evidence
demonstrating that BclA3 is a glycoprotein which is glycosylated
with chains of -O-linked GlcNAc as well as with additional gly-
cans of novel masses. Bioinformatic analysis of clostridial ge-
nomes revealed the presence of Bacillus anthracis exosporangial
bclA and bclB gene homologs. In addition, immediately upstream
of the B. anthracis bclB gene homologs in all C. difficile strains,
and shown in this study to be cotranscribed with bclA3, lies a
homolog of the neighboring B. anthracis glycosyltransferase gene
(BAS1131). While the predicted molecular mass of BclA3 based
on the translated amino acid sequence is	57 kDa, identification
of BclA3 wasmade only in higher-molecular-massmaterial found
to bemigrating inNuPAGE gels atmasses corresponding to460
kDa and which stained in a diffuse pattern by silver staining. In
addition, reactivity with glycostain in this region of the gel was
observed, suggesting that the higher-molecular-mass material
also contained carbohydrate. After repeated attempts to identify
the composition of the high-molecular-mass material using tryp-
sin digestion of selected regions of the gel, we were finally success-
ful in obtaining peptide identifications following extensive protei-
nase K digestion of the gel bands. This nLC-MS/MS analysis
identified BclA3 peptides and also provided the first evidence that
this protein is a glycoprotein. In a fashion similar to that of B.
anthracis, it appears that the BclA3 protein of C. difficile is glyco-
sylated with predominantly novel tri- or pentasaccharide oligo-
saccharides composed of chains of N-acetyl hexosamine sugars,
which may be capped with novel glycan moieties. Due to sample
limitations and capping glycan heterogeneity, we were unable to
FIG5 Restorationof anti-GlcNAc reactivity through complementation.Western
blot of cultures grown on plates for 72 h and run on 3 to 8% Nu-PAGE gel.
Complemented strains were induced with 500 ng anhydrotetracycline. Lane 1,
HiMark (Invitrogen); lane 2, R20291; lane 3, R20291CDR3194; lane 4,
R202913194p3350; lane 5, 630erm; lane 6, 6303350; lane 7, 6303350p3350.
FIG 6 Resistance of R20291 wild-type and sgtA spores to 80°C for 20 min.
Spores were incubated for 20min in awater bath at 80°C, and then the number of
CFU/mlwas determined. Percent survivalwas calculated by comparing inocula to
postheat treatment samples. P 0.0001 by t test withWelch’s correction.
FIG 7 Adherence and invasion of J774A.1 macrophage cells. Shown are the
percentages of spores adhering to or internalized into J774A.1 macrophages
after 30min of incubation at 37°C under 5%CO2. Percentages were calculated
based on known MOIs and final adhered (green/red) or internalized (red)
spores. Fifty J774A.1 cells were counted in triplicate on three independent
occasions. Statistical analysis was performed with a t test with Welch’s correc-
tion (*, P 0.05; ***, P 0.0001).
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determine the precise molecular structure, although it is clear
from glycan component neutral masses that the structural com-
position of the C. difficile BclA3 glycan is quite distinct from that
previously reported forB. anthracis (16). Gelmigration character-
istics do suggest that C. difficile BclA3 monomers from R20291
andQCD-32g58 form some sort of stable, higher-molecular-mass
complex, which is resistant to denaturation by heating and deter-
gents. In contrast, spore surface extracts of C. difficile 630 appear
to form distinct, lower-molecular-mass complexes which do not
appear to contain any BclA3 protein. In addition, spores of 630
produced a distinct pattern of -O-linked GlcNAc reactivity by
immunofluorescence studies, and the significance of these distinct
differences in spore structure between isolates remains to be de-
termined. However, -O-linked GlcNAc reactivity of spores from
a number of clinical isolates demonstrates, for the first time, the
conserved nature of this posttranslational modification on C. dif-
ficile spores. Insertional inactivation of the glycosyltransferase
gene, sgtA (CD3350 andCDR3194), provided direct evidence for a
role of the glycosyltransferase enzyme in this spore surface -O-
linked GlcNAc reactivity as well as in the production of glycosy-
lated BclA3. While previous work examining sporulation-related
gene expression demonstrated that the bclA3 gene and the adja-
cent glycosyltransferase gene (sgtA) were activated by the sporu-
lation sigma factor,
k (34, 35), this is the first study to link the sgtA
gene to a specific spore glycan-associated function.
A role for surface-associated bacterial glycans in host interac-
tions is well documented for many bacterial species (36–40). In
the current study, we show that glycans on the spore surface im-
part resistance of spores to heat treatment as well as appear to play
a role in macrophage interactions. In contrast to a previous study,
where removal of the exosporangial layer by sonication did not
affect binding and internalization of C. difficile spores by Raw
264.7 peritoneal macrophage cells (31, 41), in the current study
the loss of the ability to glycosylate surface-associated proteins
does appear to affect uptake by macrophages. It should be noted,
however, that distinct strains of C. difficile and different macro-
phage cell lines were used in each study, which may explain the
different results. It is clear, however, that C. difficile spores do
interact and are internalized bymacrophage cells and that the role
of surface-expressed glycans now can be more fully explored.
While an ability of C. difficile spores to avoid uptake by macro-
phages might be advantageous during infection, further studies
will be required to define the precise role of glycan components in
macrophage interactions. It should be noted that exosporium
structures of B. anthracis appear to mask epitopes recognized by
macrophages which are involved in induction of cytokines (42).
During the preparation of the manuscript, a detailed charac-
terization of BclA1 fromC. difficile 630 sporeswas reported (43). It
appears that the BclA1 protein forms high-molecular-mass com-
plexes in extracts of 630 spores in a similar fashion. It is significant
that the genomes of strains R20291 and QCD-32g58, which were
examined in the current study, encode a truncated bclA1 gene,
which may explain why this protein was never identified in ex-
tracts. In our analyses of the high-molecular-mass complexes ofC.
difficile 630 spores, we did not identify any BclA1 peptides and/or
glycopeptides, suggesting it forms a distinct complex. Both the
current study and the recent BclA1 study also present evidence of
additional glycoreactive bands in spore extracts, which will likely
be important in our comprehensive understanding of the glyco-
biology of C. difficile spores.
While known to be recalcitrant to proteolytic digestion and
structural characterization, the spores of Gram-positive bacterial
pathogens have gained considerable attention in recent years. The
initial demonstration that the exosporangial proteins of Bacillus
anthracis were glycoproteins which carried a pentasaccharide gly-
can containing the novel sugar, anthrose was the first example of
glycoproteins as a part of spore biology. This study has demon-
strated that spores of a second important Gram-positive patho-
gen, C. difficile, also carry novel glycoproteins on surface-associ-
ated structures. Defining the role of these structures in the
infectious process, as well as exploiting their potential in thera-
peutic and diagnostic applications, now can be further pursued.
This work adds another example to the constantly expanding data
set of protein glycosylation systems in bacterial pathogens.
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